Yes, which is why PCK hasn't priorities it for over 3 years.........
"The PainChek infant Face-Only study was developed to test the feasibility of using PainChek Infant’s face domain alone as an indicator of pain, and to evaluate it using video recordings of infants undergoing painful procedures. The study involved PainChek Infant face domain scores being compared with assessments conducted using the Revised Neonatal Facial Coding System (NFCS-R) and the Observer Visual Analogue Scale (ObsVAS). Both NFCS-R and ObsVAS are well known and validated scales used in assessing procedural pain in infants, such as vaccinations, finger and heel pricks, dressing changes or more invasive procedures such as biopsies. Findings from the study supported the validity and reliability of PainChek Infant for procedural pain assessment. Procedural pain represents a significant problem as it can have both short-term and long-term negative consequences on children’s health if not managed effectively."
https://hotcopper.com.au/threads/an...-international-regulatory-clearances.6068036/
- Forums
- ASX - By Stock
- PCK
- Media Thread
Media Thread, page-1591
-
- There are more pages in this discussion • 202 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PCK (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.0¢ |
Change
-0.001(3.23%) |
Mkt cap ! $49.11M |
Open | High | Low | Value | Volume |
3.0¢ | 3.0¢ | 3.0¢ | $12.08K | 402.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 305189 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 99999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 288356 | 0.030 |
5 | 6607448 | 0.029 |
1 | 350000 | 0.028 |
3 | 488344 | 0.027 |
4 | 1600000 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 99999 | 1 |
0.032 | 102605 | 2 |
0.033 | 126161 | 2 |
0.034 | 79638 | 2 |
0.035 | 125000 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |